Biopsy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
Biopsy devices market analysis 2036: explore cancer diagnostics trends, device forecasts, intervention volumes, pricing analysis, reimbursement insights, and competitive market dynamics.
Understand the Future of the Biopsy Devices Market
The global biopsy devices market continues to expand as rising cancer incidence and growing diagnostic intervention volumes increase demand for advanced tissue sampling technologies.
This report provides comprehensive analysis of the Biopsy Devices market within the general surgery devices sector, covering market size, segment performance, intervention volumes, pricing trends, competitive dynamics, and forecasts through 2036.
It also explores how increasing demand for cancer diagnostics, chronic disease management, and transplant-related procedures is shaping market growth across global healthcare systems.
Report Value Proposition – Why This Matters for You
Understanding diagnostic trends, device utilization, and competitive positioning is critical for companies operating within the medical devices and healthcare diagnostics market.
This report helps you:
- Analyze current and future Biopsy Devices market performance
- Track intervention volumes, pricing, and product usage trends
- Benchmark leading companies and competitive positioning
- Understand reimbursement and regulatory environments
- Identify regional and country-level growth opportunities
- Support commercialization, sourcing, and investment strategies
In addition, the report includes interactive Excel-based market models covering 39 countries with fully sourced quantitative and qualitative market intelligence.
Key Insights in the Biopsy Devices Market
Biopsy devices are used to remove tissue samples from the body for diagnostic examination and microscopic analysis.
The report covers major product categories including biopsy guns, vacuum-assisted needle devices, biopsy forceps, biopsy punches, and biopsy needles.
Increasing global cancer incidence remains one of the primary drivers of the biopsy devices market. The model also includes epidemiology analysis covering chronic kidney disease (CKD), liver cirrhosis, and kidney and liver transplantations.
The interactive market model includes annualized market revenue forecasts from 2015–2036, alongside granular data covering interventions, units, average selling prices, product usage, and market values.
The competitive landscape includes companies such as Boston Scientific Corp, Medtronic Plc, Olympus Corp, Hologic Inc, and Becton Dickinson and Co.

Scope
What You Will Learn
The report provides a structured view of the Biopsy Devices market, including:
- Market size and long-term forecasts through 2036
- Intervention volumes and product usage trends
- Average selling price and market value analysis
- Competitive landscape and company benchmarking
- Country-level reimbursement and regulatory insights
- Healthcare system and market access analysis
- Regional growth opportunities and market drivers
Target Buyers for This Report
This report is designed for professionals across healthcare and medical device industries, including:
- Biopsy and diagnostic device manufacturers
- Healthcare technology companies
- Commercial and strategy teams
- Procurement and sourcing professionals
- Investors and healthcare consultants
If you are evaluating diagnostic market opportunities, competitive positioning, or healthcare technology investments, this report provides valuable market intelligence.
How Companies Use This Report
- Medical device manufacturers
Track market opportunities and competitive positioning - Diagnostics and healthcare companies
Identify growth segments and regional demand trends - Commercial and strategy teams
Support expansion and product planning decisions - Procurement and sourcing professionals
Benchmark suppliers and technology trends - Private equity and healthcare investors
Evaluate market growth and acquisition opportunities
As a result, organizations can better position themselves within the evolving biopsy and diagnostics market.
Reasons to Buy
Benchmark Diagnostic Device Trends and Competitive Dynamics
Healthcare systems continue to prioritize faster diagnostics, minimally invasive procedures, and improved clinical outcomes across oncology and chronic disease management.
This report explores:
- Global and regional biopsy device market trends
- Competitive benchmarking and company share analysis
- Intervention volumes and pricing dynamics
- Product usage and market segmentation
- Reimbursement and medtech regulatory landscapes
- Country-specific healthcare system analysis
- SWOT and competitive dynamics assessment
The report also combines real-world healthcare datasets, primary research, and analyst commentary to support strategic decision-making.
Built on Trusted Medical Device Market Intelligence
This report combines epidemiology-based forecasting, intervention analysis, and competitive intelligence.
- Covers 39 global markets through 2036
- Includes intervention and pricing analysis
- Examines reimbursement and regulatory frameworks
- Provides company share and competitive insights
- Supports long-term strategic and investment planning
Therefore, the report delivers actionable intelligence for stakeholders across the diagnostics and medical device industry.
Devicor Medical Products Inc
Hologic Inc
Wilson-Cook Medical Inc
Boston Scientific Corp
Medtronic Plc
CONMED Corp
Olympus Corp
Argon Medical Devices Inc
Henry Schein Inc
Coloplast A/S
Merit Medical Systems Inc
Integra LifeSciences Holdings Corp
Teleflex Inc
Acuderm Inc
United States Endoscopy Group Inc
Others
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
